Recent insider share sale at current price raises slight con...
Recent insider share sale at current price raises slight concern. Lack of insider buying and low level of insider ownership over the past year do not inspire excitement about the stock.
Chief Operating Officer Of Dyne Therapeutics Sold 71% Of Their Shares
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment